HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

about

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

Item

http://www.wikidata.org/entity/Q58555325

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

@en

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

@nl

type

Item

label

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

@en

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

@nl

prefLabel

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

@en

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

@nl

P1476

HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

@en

P2093

Alexander Falkenhagen

http://www.w3.org/2001/XMLSchema#string

Sadhna Joshi

http://www.w3.org/2001/XMLSchema#string

P2860

Structural mechanism of trimeric HIV-1 envelope glycoprotein activation

A new classification for HIV-1

HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

Interaction between CD4 and class II MHC molecules mediates cell adhesion

The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes.

A lectin isolated from bananas is a potent inhibitor of HIV replication

Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults

Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children

P304

347-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTN.2018.09.003

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30340139

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

molecular medicine

P932

6197789

http://www.w3.org/2001/XMLSchema#string